You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Nadolol - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for nadolol and what is the scope of patent protection?

Nadolol is the generic ingredient in two branded drugs marketed by Uswm, Alembic, Amneal Pharms Co, Aurobindo Pharma, Beximco Pharms Usa, Chartwell Rx, Heritage Pharma, Invagen Pharms, Novast Labs, Rising, Rk Pharma, Sandoz, Teva Pharms, and Zydus Pharms, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nadolol. Seventeen suppliers are listed for this compound.

Summary for nadolol

US Patents:	0
Tradenames:	2
Applicants:	14
NDAs:	15
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	17
Raw Ingredient (Bulk) Api Vendors:	59
Clinical Trials:	23
Patent Applications:	7,861
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for nadolol
Drug Sales Revenues:	Drug sales revenues for nadolol
What excipients (inactive ingredients) are in nadolol?	nadolol excipients list
DailyMed Link:	nadolol at DailyMed

See drug prices for nadolol

See drug sales revenues for nadolol

Recent Clinical Trials for nadolol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Unity Health Toronto	N/A
The New York Community Trust	Phase 4
Weill Medical College of Cornell University	Phase 4

See all nadolol clinical trials

Pharmacology for nadolol

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for nadolol

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics

US Patents and Regulatory Information for nadolol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novast Labs	NADOLOL	nadolol	TABLET;ORAL	210786-003	Jun 1, 2018		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	NADOLOL	nadolol	TABLET;ORAL	203455-001	Dec 18, 2015	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	NADOLOL	nadolol	TABLET;ORAL	201893-001	Sep 16, 2015	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Alembic	NADOLOL	nadolol	TABLET;ORAL	211763-002	Jun 2, 2023	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva Pharms	NADOLOL	nadolol	TABLET;ORAL	074368-002	Aug 31, 1994		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Aurobindo Pharma	NADOLOL	nadolol	TABLET;ORAL	201893-002	Sep 16, 2015	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for nadolol

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-004	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-003	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-005	Oct 28, 1986	⤷ Try a Trial	⤷ Try a Trial
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-003	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.